We’re in San Sebastián 🇪🇸 with one of the top VCs in Europe, Christina Takke from V-Bio Ventures.

We talk about her path to get to the top and the benefits of gender diversity for both investing and European biotech as a whole. We also talk about her investment in Argenx when it was only three employees and the venture creation had dropped since 2022.

💎 ABOUT THE SPEAKER

Christina co-founded V-Bio Ventures in 2015 and is now the Managing Partner. Before this, she was a leader in the European Venture Capital world with 15 years of experience. She has been a partner at Forbion Capital Partners where she led many successful investments in biopharma and pharma companies.

🔗 LINKS MENTIONED

- Lean years for company creation in Europe? - BioVox, Sep 2023 - https://biovox.eu/lean-years-for-company-creation-in-europe/

📜 TRANSCRIPT

Read the full transcript here: https://flot.bio/episode/christina-takke-v-bio-ventures/

💸 DONATE

We welcome donations from individuals and businesses to support our more content creation: https://www.paypal.me/PhilipHemme⭐️

SPONSORSHIP

Ready to amplify your brand to influential leaders in biotech and biopharma? Contact nick@flot.bio and unlock sponsorship opportunities in our podcasts!

🫶 FOLLOW US

- Newsletter: http://eepurl.com/h_fnmH

- LinkedIn: https://www.linkedin.com/company/flot-bio/

- X (Twitter): https://x.com/FlotBio

🙏 LIKE/FOLLOW/REVIEW

Did you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below.

🎙️ ABOUT FLOT.BIO

Flot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 15k monthly views. Free.

⏰ TIMESTAMPS

[00:00:00 ] Intro

[00:02:03 ] Top VC woman in biotech

[00:08:36 ] European background

[00:13:49 ] Investing in Argenx at the start

[00:20:26 ] V-Bio story

[00:25:09 ] Tech transfer

[00:35:44 ] Company creation drop

[00:42:39 ] Thanks for listening